Issue Date: September 5, 2011
Merck Millipore Will Acquire Amnis
Merck Millipore, the life sciences division of Germany’s Merck KGaA, will acquire Amnis, a Seattle-based maker of high-speed cell-imaging instrumentation. Using the acquired technology, Millipore will combine flow cytometry and imaging analysis in a single system. Amnis has 40 employees and had sales of $14 million last year. “With Amnis we acquire a business with a talented workforce, a strong intellectual property position, and unique know-how,” says Jonathan DiVincenzo, head of Merck Millipore’s bioscience business.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society